1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 mL Vial, Single-dose Preservative Free, Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-4279-02
Published September 30, 2015 · Recall initiated: August 25, 2015
Summary
FDA records drug Class II recall D-1815-2015, published September 30, 2015 and initiated August 25, 2015. Recalling firm: Hospira, Inc.; Status: Ongoing; Reported quantity: 100,200 Vials; Lot: Lot #: 44-359-DK, Exp 08/01/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.
What to do
Voluntary: Firm initiated · Letter
Get an email if LIDOCAINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LIDOCAINE HYDROCHLORIDE
- Manufacturer
- Hospira, Inc.
- Distributor
- Nationwide
- Lot
- Lot #: 44-359-DK, Exp 08/01/2016
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by EnovachemJuly 8, 2026
- FDALidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices,June 10, 2026
- FDALidocaine HCl injection, USP, 1% 50mg/5mL (10 mg/mL), 5 mL Single Dose Vials, Rx only, Manufactured by: HuonsApril 22, 2026
- FDALidocaine HCl Injection, USP, 2%, 100 mg/5mL (20 mg/mL), 5 mL Single-Dose Vials, Rx only, Manufactured by:April 22, 2026
- FDARefresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant Eye Ointment, packaged in a) NetSeptember 30, 2015
- FDAEdwards Pressure Monitoring Kit with TruWave disposable pressure transducer. A sterile, single-use kit thatSeptember 23, 2015
Questions about this recall
Was 1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 mL Vial, Single-dose Preservative Free, Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-4279-02 recalled?
Yes. FDA published recall D-1815-2015 on September 30, 2015. Reported hazard: Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LIDOCAINE HYDROCHLORIDE.